ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

MIST vs GNLX // ENTERPRISE SCALE & MARKET CAP

Milestone Pharmaceuticals Inc. (NASDAQ) VS. Genelux Corporation (NASDAQ) • 15-METRIC TALLY: MIST 1 — GNLX 2
▲ ENTERPRISE SCALE & MARKET CAP LEADER: GNLX
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MIST VS. GNLX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC MIST GNLX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin — -60.00% — TIE /operating-margins <GO>
Net Profit Margin — -60.00% — TIE /net-margins <GO>
Revenue Growth (YoY) — 0.00% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 1/9 2/9 -1.00 GNLX /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 43.9 37.3 +6.60 MIST /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap ACTIVE $89.8M $90.5M -$715.2K GNLX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR MIST REV GNLX REV MIST GROSS % GNLX GROSS % MIST FCF GNLX FCF
FY 2025 $174.0M $8.0K — — -$49.3M -$26.4M
FY 2024 $117.9M $8.0K — — -$28.9M -$21.6M
FY 2023 $171.1M $170.0K — — -$46.4M -$20.3M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MIST // BETA —
GNLX // BETA —